2,528
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Visual Impairment, Eye Disease, and the 3-year Incidence of Depressive Symptoms: The Canadian Longitudinal Study on Aging

, , , &
Pages 77-85 | Received 30 Jul 2020, Accepted 03 Sep 2020, Published online: 24 Sep 2020

References

  • Flaxman SR, Bourne RRA, Resnikoff S, et al. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(12):e1221–e1234. doi:10.1016/S2214-109X(17)30393-5.
  • Reinhardt JP, Boerner K, Horowitz A. Personal and social resources and adaptation to chronic vision impairment over time. Aging & Mental Health. 2009;13(3):367–375. doi:10.1080/13607860902860912.
  • Friedman DS, Okeke CO, Jampel HD, et al. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma. Ophthalmology. 2009;116(6):1097–1105. doi:10.1016/j.ophtha.2009.01.021.
  • Chen AJ, Hwang V, Law PY, Stewart JM, Chao DL. Factors Associated with Non-compliance for Diabetic Retinopathy Follow-up in an Urban Safety-Net Hospital. Ophthalmic Epidemiol. 2018;25(5–6):443–450. doi:10.1080/09286586.2018.1504311.
  • Brody BL, Gamst AC, Williams RA, et al. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology. 2001;108(10):1893–1900. doi:10.1016/S0161-6420(01)00754-0. discussion 1900-1891.
  • Casten RJ, Rovner BW, Tasman W. Age-related macular degeneration and depression: a review of recent research. Curr Opin Ophthalmol. 2004;15(3):181–183. doi:10.1097/01.icu.0000120710.35941.3f.
  • Mabuchi F, Yoshimura K, Kashiwagi K, et al. High prevalence of anxiety and depression in patients with primary open-angle glaucoma. J Glaucoma. 2008;17(7):552–557. doi:10.1097/IJG.0b013e31816299d4.
  • van der Aa HP, Comijs HC, Penninx BW, van Rens GH, van Nispen RM. Major depressive and anxiety disorders in visually impaired older adults. Invest Ophthalmol Vis Sci. 2015;56(2):849–854. doi:10.1167/iovs.14-15848.
  • Wang H, Sun HP, Wang P, Xu Y, Pan CW. Cataract and Depressive Symptoms among Older Chinese Adults. Optom Vis Sci. 2016;93(12):1479–1484. doi:10.1097/OPX.0000000000000960.
  • Eramudugolla R, Wood J, Anstey KJ. Co-morbidity of depression and anxiety in common age-related eye diseases: a population-based study of 662 adults. Front Aging Neurosci. 2013;5:56. doi:10.3389/fnagi.2013.00056.
  • Zheng DD, Bokman CL, Lam BL, et al. Longitudinal relationships between visual acuity and severe depressive symptoms in older adults: the Salisbury Eye Evaluation study. Aging & Mental Health. 2016;20(3):295–302. doi:10.1080/13607863.2015.1008985.
  • Hong T, Mitchell P, Burlutsky G, Gopinath B, Liew G, Wang JJ. Visual impairment and depressive symptoms in an older Australian cohort: longitudinal findings from the Blue Mountains Eye Study. British J Ophthalmol. 2015;99(8):1017–1021. doi:10.1136/bjophthalmol-2014-306308.
  • Tournier M, Moride Y, Ducruet T, Moshyk A, Rochon S. Depression and mortality in the visually-impaired, community-dwelling, elderly population of Quebec. Acta Ophthalmol. 2008;86(2):196–201. doi:10.1111/j.1600-0420.2007.01024.x.
  • Chen YY, Lai YJ, Wang JP, et al. The association between glaucoma and risk of depression: A nationwide population-based cohort study. BMC Ophthalmol. 2018;18(1):146–147. doi:10.1186/s12886-018-0811-5.
  • Wysong A, Lee PP, Sloan FA. Longitudinal incidence of adverse outcomes of age-related macular degeneration. Arch Ophthalmol. 2009;127(3):320–327. doi:10.1001/archophthalmol.2008.613.
  • Chen PW, Liu PP, Lin SM, Wang JH, Huang HK, Loh CH. Cataract and the increased risk of depression in general population: a 16-year nationwide population-based longitudinal study. Sci Rep. 2020;10(1):13421. doi:10.1038/s41598-020-70285-7.
  • Prince MJ, Harwood RH, Thomas A, Mann AH. A prospective population-based cohort study of the effects of disablement and social milieu on the onset and maintenance of late-life depression. The Gospel Oak Project VII. Psychol Med. 1998;28(2):337–350. doi:10.1017/S0033291797006478.
  • Forsell Y. Predictors for Depression, Anxiety and psychotic symptoms in a very elderly population: data from a 3-year follow-up study. Soc Psychiatry Psychiatr Epidemiol. 2000;35(6):259–263. doi:10.1007/s001270050237.
  • Heesterbeek TJ, HPA VDA, GHMB VR, Twisk JWR, van Nispen RMA. The incidence and predictors of depressive and anxiety symptoms in older adults with vision impairment: a longitudinal prospective cohort study. Ophthalmic Physiol Opt. 2017;37(4):385–398. doi:10.1111/opo.12388.
  • Harris T, Cook DG, Victor C, DeWilde S, Beighton C. Onset and persistence of depression in older people - Results from a 2-year community follow-up study. Age Ageing. 2006;35(1):25–32. doi:10.1093/ageing/afi216.
  • Brown RL, Barrett AE. Visual impairment and quality of life among older adults: an examination of explanations for the relationship. J Gerontol. 2011;66 B(3):364–373. doi:10.1093/geronb/gbr015.
  • Choi HG, Lee MJ, Lee SM. Visual impairment and risk of depression: A longitudinal follow-up study using a national sample cohort. Sci Rep. 2018;8(1):2083–2084. doi:10.1038/s41598-018-20374-5.
  • Frank CR, Xiang X, Stagg BC, Ehrlich JR. Longitudinal associations of self-reported vision impairment with symptoms of anxiety and depression among older adults in the United States. JAMA Ophthalmol. 2019;137(7):793–800. doi:10.1001/jamaophthalmol.2019.1085.
  • Heine C, Browning CJ. Mental health and dual sensory loss in older adults: a systematic review. Front Aging Neurosci. 2014;6:83. doi:10.3389/fnagi.2014.00083.
  • Rorsman B, Grasbeck A, Hagnell O, et al. A prospective study of first-incidence depression. The Lundby study, 1957-72. Br J Psychiatry. 1990;156(3):336–342. doi:10.1192/bjp.156.3.336.
  • Raina P, Wolfson C, Kirkland S, et al. Cohort Profile: the Canadian Longitudinal Study on Aging (CLSA). Int J Epidemiol. 2019;48(6):1752–1753j. doi:10.1093/ije/dyz173.
  • Ferris FL 3rd, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol. 1982;94(1):91–96. doi:10.1016/0002-9394(82)90197-0.
  • Aljied R, Aubin MJ, Buhrmann R, Sabeti S, Freeman EE. Prevalence and determinants of visual impairment in Canada: cross-sectional data from the Canadian longitudinal study on aging. Can J Ophthalmol. 2018;53(3):291–297. doi:10.1016/j.jcjo.2018.01.027.
  • Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med. 1994;10(2):77–84. doi:10.1016/S0749-3797(18)30622-6.
  • Guralnik JM. Assessing the impact of comorbidity in the older population. Ann Epidemiol. 1996;6(5):376–380. doi:10.1016/S1047-2797(96)00060-9.
  • McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol. 2003;157(10):940–943. doi:10.1093/aje/kwg074.
  • Kessler RC, Foster C, Webster PS, House JS. The relationship between age and depressive symptoms in two national surveys. Psychol Aging. 1992;7(1):119–126. doi:10.1037/0882-7974.7.1.119.
  • van de Leemput IA, Wichers M, Cramer AO, et al. Critical slowing down as early warning for the onset and termination of depression. Proc Natl Acad Sci U S A. 2014;111(1):87–92. doi:10.1073/pnas.1312114110.
  • Wilson MR, Coleman AL, Yu F, Fong Sasaki I, Bing EG, Kim MH. Depression in patients with glaucoma as measured by self-report surveys. Ophthalmology. 2002;109(5):1018–1022. doi:10.1016/S0161-6420(02)00993-4.
  • Jampel HD, Frick KD, Janz NK, et al. Depression and mood indicators in newly diagnosed glaucoma patients. Am J Ophthalmol. 2007;144(2):238–244. doi:10.1016/j.ajo.2007.04.048.
  • Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–267. doi:10.1136/bjo.2005.081224.
  • Linton KL, Klein BE, Klein R. The validity of self-reported and surrogate-reported cataract and age-related macular degeneration in the Beaver Dam Eye Study. Am J Epidemiol. 1991;134(12):1438–1446. doi:10.1093/oxfordjournals.aje.a116049.
  • Patty L, Wu C, Torres M, Azen S, Varma R. Los Angeles latino eye study G. Validity of self-reported eye disease and treatment in a population-based study: the Los Angeles Latino Eye Study. Ophthalmology. 2012;119(9):1725–1730. doi:10.1016/j.ophtha.2012.02.029.
  • Friedman DS, Wolfs RC, O’Colmain BJ, et al. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol. 2004;122(4):532–538.
  • Congdon N, Vingerling JR, Klein BE, et al. Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch Ophthalmol. 2004;122(4):487–494.
  • Friedman DS, O’Colmain BJ, Munoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122(4):564–572.
  • Gougeon L, Payette H, Morais J, Gaudreau P, Shatenstein B, Gray-Donald K. Dietary patterns and incidence of depression in a cohort of community-dwelling older Canadians. J Nutrition, Health Aging. 2015;19(4):431–436. doi:10.1007/s12603-014-0562-9.
  • Mueller TI, Leon AC, Keller MB, et al. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry. 1999;156(7):1000–1006.
  • van der Aa HP, van Rens GH, Comijs HC, et al. Stepped care for depression and anxiety in visually impaired older adults: multicentre randomised controlled trial. BMJ. 2015;351:h6127. doi:10.1136/bmj.h6127.
  • Kamga H, McCusker J, Yaffe M, et al. Self-care tools to treat depressive symptoms in patients with age-related eye disease: a randomized controlled clinical trial. Clin Exp Ophthalmol. 2017;45(4):371–378. doi:10.1111/ceo.12890.